InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Baik Brian Seung Won(백승원), 董事长兼首席执行官. Officer active across 2 companies, notably 케이엠제약. Aggregated, 11 filings have been logged. Activity tracked since 9 March 2026. The latest transaction was disclosed on 15 April 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
BAIK BRIAN SEUNG WON is the Chairman & CEO of KM Pharmaceutical. He is responsible for the strategic direction of the company and the management of daily operations. With his experience, BAIK BRIAN SEUNG WON plays a key role in strategic decision-making and defining the company's long-term vision.